Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Colorectal Patients Offered New Resource to Help Navigate Treatment Process.


- Patient Advocate Foundation and Amgen Oncology Launch Colorectal CareLine -

NEWPORT NEWS, Va. & THOUSAND OAKS, Calif. -- The Patient Advocate Foundation (PAF PAF platelet activating factor.

PAF
abbr.
platelet-aggregating factor



PAF

platelet activating factor.
), with support from Amgen (Nasdaq:AMGN), is pleased to announce the launch of the Colorectal CareLine (CCL 1. CCL - Coral Common LISP.
2. CCL - Computer Control Language. English-like query language based on COLINGO, for IBM 1401 and IBM 1410.
). The national toll free telephone hotline is designed to offer assistance to all colorectal cancer colorectal cancer

Malignant tumour of the large intestine (colon) or rectum. Risk factors include age (after age 50), family history of colorectal cancer, chronic inflammatory bowel diseases, benign polyps, physical inactivity, and a diet high in fat.
 patients and healthcare providers seeking educational resources, direct assistance with access to care issues and/or financial aid for select patient needs, including lodging, transportation, childcare and other expenses associated with out-of-town treatment. The hotline can be accessed at 1-866-657-8634 or patients may visit www.colorectalcareline.org.

Staffed by a dedicated team of multilingual clinical case managers with nursing and social work experience, the Colorectal CareLine offers personal case management services, including the dissemination of disease information, direction on how to obtain financial assistance, availability of clinical trials, and guidance in managing the reimbursement process.

"Navigating the reimbursement system in order to obtain prescribed care and accessing available financial and educational resources following a diagnosis of colorectal cancer can be confusing and overwhelming for patients," said Beth Darnley, chief program officer at the Patient Advocate Foundation. "Options such as the Colorectal CareLine offer a centralized resource for information and direct support to help patients and their healthcare providers manage this serious disease."

The Colorectal CareLine is the latest addition to PAF's portfolio of patient services. The Foundation's existing programs include direct case management services, the National Hispanic/Latino, African American African American Multiculture A person having origins in any of the black racial groups of Africa. See Race.  and Senior Outreach initiatives, Hematologic hematological, hematologic

pertaining to or emanating from blood cells.


hematological tests
total and differential white cell counts, hematocrit estimation, erythrocyte count.
 Cancer Education Program and the national Livestrong SurvivorCare partnership.

"Amgen is proud to support PAF's Colorectal CareLine," said Cynthia Schwalm, vice president and general manager, oncology at Amgen. "The toll free number will help ensure that colorectal cancer patients have the information and tools they need to get through their treatment."

In an effort to spread the word about the Colorectal CareLine to the community, PAF will partner with several advocacy and patient groups to ensure the patients that need these services learn about them. The Colorectal CareLine is funded by a donation from Amgen.

Patient Advocate Foundation

Patient Advocate Foundation is a national non-profit organization that seeks to safeguard patients through effective mediation assuring access to care, maintenance of employment and preservation of their financial stability.

More information may be obtained at www.patientadvocate.org or by calling (800) 532-5274.

About Colorectal Cancer

Colorectal cancer is the third most common cancer diagnosed in men and womenCoand the second leading cause of cancer death - in the United States (after lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. ). The American Cancer Society American Cancer Society,
n.pr established in 1913, this national volunteer-based health organization is committed to the elimination of cancer through prevention and treatment and to diminishing cancer suffering through advocacy, scholarship, research,
 estimates that about 146,940 new cases of colon cancer colon cancer, cancer of any part of the colon (often called the large intestine). Colon cancer is the second most common cancer diagnosed in the United States.  and 41,930 new cases of rectal cancer Rectal Cancer Definition

The rectum is the portion of the large bowel that lies in the pelvis, terminating at the anus. Cancer of the rectum is the disease characterized by the development of malignant cells in the lining or epithelium of the rectum.
 will be diagnosed in 2006. It has been estimated that 56,370 people will die from colorectal cancer in 2006. That means that one person in the United States dies of colorectal cancer every 9.3 minutes.

About Amgen

Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease Kidney Disease Definition

Kidney disease is a general term for any damage that reduces the functioning of the kidney. Kidney disease is also called renal disease.
, rheumatoid arthritis rheumatoid arthritis

Chronic, progressive autoimmune disease causing connective-tissue inflammation, mostly in synovial joints. It can occur at any age, is more common in women, and has an unpredictable course.
, and other serious illnesses. With a broad and deep pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 29, 2006
Words:582
Previous Article:Dinnertime is the Right Time for California Pizza Kitchen.
Next Article:PEAK Technologies Earns Advanced WLAN Certification from Cisco(R) Systems.
Topics:



Related Articles
Cancer study patients being sought.
Aspirin may decrease risk of colon cancer.
Cancer treatment: does age bias interfere?
FDA approves Eloxatin for colorectal cancer.
Treatment combinations stall colorectal cancer. (Cancer Advance).
Screening preferences for colorectal cancer: a patient demographic study.
Compassionate-use oxaliplatin with bolus 5-fluorouracil/leucovorin in heavily pretreated patients with advanced colorectal cancer.
Cutaneous metastases of signet cell carcinoma of the rectum without accompanying visceral involvement.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles